# Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas

> **NCT05969691** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Mingge LLC** · enrollment: 18 (actual)

## Conditions studied

- Glioma, Malignant
- Computer-Assisted

## Interventions

- **DIAGNOSTIC_TEST:** Validation of IDH1 mutations from the radiomics model

## Key facts

- **NCT ID:** NCT05969691
- **Lead sponsor:** Mingge LLC
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2019-03-15
- **Primary completion:** 2025-12-15
- **Final completion:** 2026-12-15
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-08-08

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05969691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05969691, "Radiomics-Based Visualization and Quantitative Validation of IDH1 Heterogeneity in Gliomas". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05969691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*